Inari Medical, Inc.(NARI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

NARI Inari Medical, Inc.

Trading 11-04 13:17:19 EST

49.28

+0.54

+1.11%

High50.06	Low48.62	Vol227.91K
Open48.74	D1 Closing48.74	Amplitude2.95%
Mkt Cap2.89B	Tradable Cap2.63B	Total Shares58.54M
T/O11.23M	T/O Rate0.43%	Tradable Shares53.37M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"NARI","market":"US","secType":"STK","nameCN":"Inari Medical, Inc.","latestPrice":49.28,"timestamp":1730744238513,"preClose":48.74,"halted":0,"volume":227907,"delay":0,"floatShares":53368093,"shares":58544158,"eps":-1.354304,"marketStatus":"Trading","change":0.54,"latestTime":"11-04 13:17:19 EST","open":48.74,"high":50.06,"low":48.62,"amount":11227195.65726,"amplitude":0.029545,"askPrice":49.29,"askSize":109,"bidPrice":49.25,"bidSize":14,"shortable":3,"etf":0,"ttmEps":-1.354304,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Market Trading","tradingStatus":3,"beginTime":1730754000000},"marketStatusCode":2,"adr":0,"listingDate":1590120000000,"exchange":"NASDAQ","adjPreClose":48.74,"postHourTrading":{"tag":"盘后","latestPrice":47.7,"preClose":48.74,"latestTime":"17:23 EDT","volume":29500,"amount":1436810.31,"timestamp":1730496192224},"volumeRatio":0.245269,"impliedVol":0.5716,"impliedVolPercentile":0.494},"requestUrl":"/m/hq/s/NARI","defaultTab":"news","newsList":[{"id":"2479201425","title":"Inari Medical Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags","url":"https://stock-news.laohu8.com/highlight/detail?id=2479201425","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479201425?lang=en_us&edition=fundamental","pubTime":"2024-10-30 20:19","pubTimestamp":1730290746,"startTime":"0","endTime":"0","summary":"NasdaqGS:NARI Earnings and Revenue Growth October 30th 2024. All figures shown in the chart above are for the trailing 12 month  period. Revenue exceeded analyst estimates by 1.8%. Earnings per share  missed analyst estimates by 68%.Looking ahead, revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 8.3% growth forecast for the Medical Equipment industry in the US.The company's shares are up 11% from a week ago.We don't want to rain on the parade too much, but we did also find 1 warning sign for Inari Medical that you need to be mindful of.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/inari-medical-third-quarter-2024-121906838.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NARI"],"gpt_icon":0},{"id":"1121951038","title":"Stock Track | Inari Medical Soars on Stellar Q3 Results, Upbeat Outlook, and Positive Trial Data","url":"https://stock-news.laohu8.com/highlight/detail?id=1121951038","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121951038?lang=en_us&edition=fundamental","pubTime":"2024-10-30 09:18","pubTimestamp":1730251125,"startTime":"0","endTime":"0","summary":"Shares of Inari Medical, Inc.  skyrocketed 19.67% on October 29, 2024, after the medical device company reported impressive third-quarter financial results, raised its full-year revenue guidance, and announced positive results from a pivotal clinical trial for its flagship product.Building on the solid performance, Inari Medical raised its full-year 2024 revenue guidance to a range of $601.5 million to $604.5 million, reflecting an increase of $3.5 million at the midpoint from its prior outlook.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["NARI"],"gpt_icon":0},{"id":"2479231588","title":"Inari Medical Inc (NARI) Q3 2024 Earnings Call Highlights: Record Revenue and Raised Guidance ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2479231588","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479231588?lang=en_us&edition=fundamental","pubTime":"2024-10-30 01:01","pubTimestamp":1730221283,"startTime":"0","endTime":"0","summary":"Global VTE Revenue: $145.3 million, up 19.7% year-over-year.Global Emerging Therapies Revenue: $8 million, up 64% year-over-year.Gross Margin: 87.1%, compared to 88.5% in the prior year period.Operating Expenses: $147.1 million, compared to $109.8 million in the prior year.R&D Expense: $29.4 million, compared to $21.5 million in the prior year.GAAP Operating Loss: $13.6 million, compared to GAAP operating income of $2.1 million in the prior year.Net Loss: $18.4 million, compared to net income of $3.2 million in the prior year.Cash and Investments: $111.6 million at the end of the third quarter.2024 Revenue Guidance: Raised to $601.5 to $604.5 million, reflecting growth of 22 to 22.5% over 2023.Inari Medical Inc  reported record revenue of $153.4 million for Q3 2024, marking a 21% year-over-year growth.The street is modeling VTE revenue growth in the low to mid 10s, which seems to lag behind your previous guidance of 18% to 22%. A: Our view is that the market was stable in Q3, with stab","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/LJUGa9c2cq8YNhngHDkuSA--~B/aD00OTc7dz00OTc7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/a95bc9bca3baf9a4bdcd7da610fa0423","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/LJUGa9c2cq8YNhngHDkuSA--~B/aD00OTc7dz00OTc7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/a95bc9bca3baf9a4bdcd7da610fa0423"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/inari-medical-inc-nari-q3-170123148.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NARI"],"gpt_icon":0},{"id":"2479239134","title":"Inari Medical's FlowTriever Outperforms Catheter-Directed Thrombolytics in Pulmonary Embolism Treatment; Shares Up","url":"https://stock-news.laohu8.com/highlight/detail?id=2479239134","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479239134?lang=en_us&edition=fundamental","pubTime":"2024-10-30 00:58","pubTimestamp":1730221114,"startTime":"0","endTime":"0","summary":"Inari Medical  said Tuesday that treatment with FlowTriever showed superiority compared with catheter-directed thrombolytics or CDT in a randomized study that enrolled 550 intermediate-risk pulmonary embolism patients.The company said the study achieved its primary composite endpoint, with patients experiencing three times fewer clinical deteriorations and/or therapy escalations, and \"significantly less\" intensive care unit admission and length of stay with FlowTriever compared with CDT.Inari shares advanced more than 10% in recent trading.Price: 46.96, Change: +4.40, Percent Change: +10.34","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NARI"],"gpt_icon":0},{"id":"2479423376","title":"Inari Medical reports PEERLESS study met primary composite endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2479423376","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479423376?lang=en_us&edition=fundamental","pubTime":"2024-10-30 00:06","pubTimestamp":1730217978,"startTime":"0","endTime":"0","summary":"Inari Medical (NARI) announced “positive” results from the prospective PEERLESS Randomized Controlled Trial comparing FlowTriever to catheter-direc...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/inari-medical-reports-peerless-study-met-primary-composite-endpoint?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/inari-medical-reports-peerless-study-met-primary-composite-endpoint?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NARI","LU0390134368.USD","BK4082"],"gpt_icon":0},{"id":"2479338322","title":"PEERLESS Results Show Superiority of FlowTriever® Compared to Catheter-Directed Thrombolytics for Intermediate-Risk Pulmonary Embolism","url":"https://stock-news.laohu8.com/highlight/detail?id=2479338322","media":"GlobeNewswire","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479338322?lang=en_us&edition=fundamental","pubTime":"2024-10-29 23:56","pubTimestamp":1730217360,"startTime":"0","endTime":"0","summary":"Primary endpoint win driven by both hard clinical outcomes and hospital resource utilizationIRVINE, Calif., Oct.  29, 2024  (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/10/29/2971058/0/en/PEERLESS-Results-Show-Superiority-of-FlowTriever-Compared-to-Catheter-Directed-Thrombolytics-for-Intermediate-Risk-Pulmonary-Embolism.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","BK4082","LU1878469433.USD","PI","LU0390134368.USD","NARI","CDT","BK4141"],"gpt_icon":1},{"id":"2479286127","title":"Bank of America Securities Remains a Buy on Inari Medical (NARI)","url":"https://stock-news.laohu8.com/highlight/detail?id=2479286127","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479286127?lang=en_us&edition=fundamental","pubTime":"2024-10-29 22:06","pubTimestamp":1730210782,"startTime":"0","endTime":"0","summary":"Bank of America Securities analyst Travis Steed maintained a Buy rating on Inari Medical (NARI – Research Report) today. The company’s shares opene...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bank-of-america-securities-remains-a-buy-on-inari-medical-nari-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bank-of-america-securities-remains-a-buy-on-inari-medical-nari-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0321505868.SGD","IE00BLSP4239.USD","LU1280957306.USD","NARI","LU0306806265.USD","BK4559","BK4581","BK4504","LU0256863811.USD","IE00BBT3K403.USD","LU1201861249.SGD","LU0640476718.USD","LU0106831901.USD","LU0980610538.SGD","LU0648000940.SGD","LU1074936037.SGD","BK4082","LU0320765489.SGD","IE00B19Z3B42.SGD","LU0130518102.USD","LU0053666078.USD","LU1363072403.SGD","IE00B7SZLL34.SGD","LU0320765646.SGD","IE00BKVL7J92.USD","LU1791807156.HKD","LU2129689514.USD","LU1162221912.USD","LU1201861165.SGD","LU2129689431.USD","BAC","LU0868494617.USD","BK4585","IE0002270589.USD","LU0417517546.SGD","IE00BZ1G4Q59.USD","BK4553","IE00BLSP4452.SGD","LU0321505439.SGD","LU1496350171.SGD","LU0208291251.USD","LU0306807586.USD","LU0130103400.USD","LU0098860793.USD","LU0310800965.SGD","LU0256863902.USD","LU1496350502.SGD","LU0390134368.USD","LU1267930227.SGD","LU0648001328.SGD"],"gpt_icon":0},{"id":"2479283911","title":"Inari Medical price target raised to $50 from $46 at Truist","url":"https://stock-news.laohu8.com/highlight/detail?id=2479283911","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479283911?lang=en_us&edition=fundamental","pubTime":"2024-10-29 21:50","pubTimestamp":1730209811,"startTime":"0","endTime":"0","summary":"Truist raised the firm’s price target on Inari Medical (NARI) to $50 from $46 and keeps a Hold rating on the shares. The company’s Q3 profit beat s...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/inari-medical-price-target-raised-to-50-from-46-at-truist?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/inari-medical-price-target-raised-to-50-from-46-at-truist?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NARI"],"gpt_icon":0},{"id":"1128052470","title":"Stock Track | Inari Medical Soars on Strong Q3 Results, Upbeat Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=1128052470","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128052470?lang=en_us&edition=fundamental","pubTime":"2024-10-29 21:37","pubTimestamp":1730209066,"startTime":"0","endTime":"0","summary":"Shares of Inari Medical, Inc.  surged 12.08% on October 29, 2024, after the medical device company reported impressive third-quarter results and raised its full-year revenue guidance.For the third quarter ended September 30, 2024, Inari Medical posted revenue of $153.4 million, a 21.4% increase compared to the same period last year. The strong revenue growth was driven by an expansion in sales territories, opening of new accounts, increased adoption of the company's procedures, global commercial","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["NARI"],"gpt_icon":0},{"id":"2479288827","title":"Inari Medical Shares up 14% After Co Raises FY2024 Revenue Forecast","url":"https://stock-news.laohu8.com/highlight/detail?id=2479288827","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479288827?lang=en_us&edition=fundamental","pubTime":"2024-10-29 21:34","pubTimestamp":1730208876,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241029:nFWN3M51CB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0390134368.USD","NARI","BK4082"],"gpt_icon":0},{"id":"2479404941","title":"Inari Medical Inc : Canaccord Genuity Raises Target Price to $74 From $71","url":"https://stock-news.laohu8.com/highlight/detail?id=2479404941","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479404941?lang=en_us&edition=fundamental","pubTime":"2024-10-29 20:49","pubTimestamp":1730206151,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241029:nFWN3M51EL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NARI","LU0390134368.USD","BK4082"],"gpt_icon":0},{"id":"2479409224","title":"Inari Medical Is Maintained at Buy by Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2479409224","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479409224?lang=en_us&edition=fundamental","pubTime":"2024-10-29 20:22","pubTimestamp":1730204520,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/NARI/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  October 29, 2024 08:22 ET (12:22 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NARI"],"gpt_icon":0},{"id":"2479064074","title":"Inari Medical Is Maintained at Outperform by Baird","url":"https://stock-news.laohu8.com/highlight/detail?id=2479064074","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479064074?lang=en_us&edition=fundamental","pubTime":"2024-10-29 20:10","pubTimestamp":1730203800,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/NARI/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  October 29, 2024 08:10 ET (12:10 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NARI"],"gpt_icon":0},{"id":"2479409658","title":"BUZZ-U.S. STOCKS ON THE MOVE-McDonald's, Zebra Technologies, Pfizer","url":"https://stock-news.laohu8.com/highlight/detail?id=2479409658","media":"Reuters","labels":["Business Data"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479409658?lang=en_us&edition=fundamental","pubTime":"2024-10-29 20:05","pubTimestamp":1730203545,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-McDonald's, Zebra Technologies, PfizerEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newslet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ca5fccc33a5f91842e4d17dcec823d1b","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241029:nL4N3M51FM:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"Business Data","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RCL","AAPL","LU0321505868.SGD","BK4142","LU0267386448.USD","LU0128525929.USD","LU1914381329.SGD","MCD","SG9999003800.SGD","T","FLG","GLYC","DBGI","IE00BSNM7G36.USD","KDP","HRYU","LU1162221912.USD","LU1244550221.USD","LU2324357040.USD","VFC","GLW","BK4559","PFE","LU0289739699.SGD","CVI","IE00B3SWFQ91.USD","IEP","BK4581","LU0985481810.HKD","IE0004445015.USD","ZBRA","BKYI","LU0149725797.USD","LU1883839398.USD","BK4585","IE00BLSP4239.USD","TMDX","DTE","VZ","PYPL","GOOGL","IE00BK4W5M84.HKD","LU0868494617.USD","TMUS","BK4122","AMWL","NARI","LU0098860793.USD","LU0130102774.USD","HK0000320223.HKD"],"gpt_icon":1},{"id":"2479940550","title":"Truist Raises Price Target on Inari Medical to $50 From $46, Keeps Hold Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2479940550","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479940550?lang=en_us&edition=fundamental","pubTime":"2024-10-29 19:54","pubTimestamp":1730202872,"startTime":"0","endTime":"0","summary":"Inari Medical (NARI) has an average investment rating of outperform among analysts polled by Capital IQ, with price targets ranging from $48 to $86.(MT Newswires covers equity, commodity and economic ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NARI"],"gpt_icon":0},{"id":"2479470045","title":"BUZZ-Inari climbs after slightly raising annual revenue forecast","url":"https://stock-news.laohu8.com/highlight/detail?id=2479470045","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479470045?lang=en_us&edition=fundamental","pubTime":"2024-10-29 19:21","pubTimestamp":1730200896,"startTime":"0","endTime":"0","summary":"** Shares of medical device maker Inari Medical    rise ~7% to $45.56 premarket   ** Inari, late on Monday, raised the lower end of its full year 2024 revenue forecast to $601.5 million to $604.5 million, from its prior range of $594.5 million to $604.5 million   ** Co's Q3 revenue of $153.39 mln beats analysts' average expectation of $150.67 mln - LSEG   ** Co continues to expect to reach sustained operating profitability in first half of 2025        ** At least two analysts have raised co's PT after results   ** Up to last close, stock down 34.4% YTD ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NARI"],"gpt_icon":1},{"id":"1105344574","title":"Stock Track | Inari Medical Soars in Pre-Market on Strong Q3 Results and Upbeat Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=1105344574","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105344574?lang=en_us&edition=fundamental","pubTime":"2024-10-29 18:34","pubTimestamp":1730198087,"startTime":"0","endTime":"0","summary":"Inari Medical, Inc.  shares surged 8.06% in pre-market trading on October 29, 2024, following the company's impressive third-quarter financial results and raised full-year revenue guidance.For the third quarter ended September 30, 2024, Inari Medical reported revenue of $153.4 million, representing a 21.4% increase compared to the same period last year. The strong revenue growth was driven by an expansion in sales territories, opening of new accounts, increased adoption of the company's procedur","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["NARI"],"gpt_icon":0},{"id":"1159179939","title":"Stock Track | Inari Medical Soars on Strong Q3 Results and Upbeat Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=1159179939","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159179939?lang=en_us&edition=fundamental","pubTime":"2024-10-29 17:54","pubTimestamp":1730195672,"startTime":"0","endTime":"0","summary":"Shares of Inari Medical, Inc.  surged 12.03% on October 28, 2024, after the medical device company reported impressive third-quarter results and raised its full-year revenue guidance.For the third quarter ended September 30, 2024, Inari Medical posted revenue of $153.4 million, a 21.4% increase compared to the same period last year. The strong revenue growth was driven by an expansion in sales territories, opening of new accounts, increased adoption of the company's procedures, global commercial","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["NARI"],"gpt_icon":0},{"id":"2479473248","title":"Inari Medical’s Strong Performance and Growth Catalysts Lead to Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2479473248","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479473248?lang=en_us&edition=fundamental","pubTime":"2024-10-29 17:46","pubTimestamp":1730195189,"startTime":"0","endTime":"0","summary":"Morgan Stanley analyst Kallum Titchmarsh has maintained their bullish stance on NARI stock, giving a Buy rating yesterday. Kallum Titchmarsh’s rati...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/inari-medicals-strong-performance-and-growth-catalysts-lead-to-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/inari-medicals-strong-performance-and-growth-catalysts-lead-to-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NARI"],"gpt_icon":0},{"id":"2479737594","title":"Inari Medical’s Strong Financial Performance and Growth Prospects Bolster Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2479737594","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479737594?lang=en_us&edition=fundamental","pubTime":"2024-10-29 17:45","pubTimestamp":1730195125,"startTime":"0","endTime":"0","summary":"BTIG analyst Marie Thibault maintained a Buy rating on Inari Medical (NARI – Research Report) yesterday and set a price target of $86.00. Marie Thi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/inari-medicals-strong-financial-performance-and-growth-prospects-bolster-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/inari-medicals-strong-financial-performance-and-growth-prospects-bolster-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NARI"],"gpt_icon":0}],"profile":{"websiteUrl":"https://www.inarimedical.com","stockEarnings":[{"period":"1week","weight":0.1153},{"period":"1month","weight":0.1383},{"period":"3month","weight":0.0302},{"period":"6month","weight":0.1596},{"period":"1year","weight":-0.0441},{"period":"ytd","weight":-0.2492}],"compareEarnings":[{"period":"1week","weight":-0.0138},{"period":"1month","weight":0.0038},{"period":"3month","weight":0.0716},{"period":"6month","weight":0.1169},{"period":"1year","weight":0.3257},{"period":"ytd","weight":0.2014}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.081523},{"month":2,"riseRate":0.5,"avgChangeRate":0.022055},{"month":3,"riseRate":1,"avgChangeRate":0.047729},{"month":4,"riseRate":0.5,"avgChangeRate":-0.046873},{"month":5,"riseRate":0.25,"avgChangeRate":-0.043859},{"month":6,"riseRate":0.6,"avgChangeRate":0.026515},{"month":7,"riseRate":0.4,"avgChangeRate":0.042564},{"month":8,"riseRate":0.4,"avgChangeRate":0.064666},{"month":9,"riseRate":0.2,"avgChangeRate":-0.032558},{"month":10,"riseRate":0.6,"avgChangeRate":0.047252},{"month":11,"riseRate":0.4,"avgChangeRate":-0.019625},{"month":12,"riseRate":0.75,"avgChangeRate":0.08025}],"exchange":"NASDAQ","name":"Inari Medical, Inc.","nameEN":"Inari Medical, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Inari Medical, Inc.(NARI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Inari Medical, Inc.(NARI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Inari Medical, Inc.,NARI,Inari Medical, Inc.股票,Inari Medical, Inc.股票老虎,Inari Medical, Inc.股票老虎国际,Inari Medical, Inc.行情,Inari Medical, Inc.股票行情,Inari Medical, Inc.股价,Inari Medical, Inc.股市,Inari Medical, Inc.股票价格,Inari Medical, Inc.股票交易,Inari Medical, Inc.股票购买,Inari Medical, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Inari Medical, Inc.(NARI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Inari Medical, Inc.(NARI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}